Resistant Starch and metabolic health
What 2 graded rows on resistant starch agree on for metabolic health, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Resistant Starch page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Resistant Starch page, with its PubMed record.
Your question
Resistant Starch and metabolic health
2 rows · 1,743 peopleInconsistent: both rows reported mixed results.
- CGrade C× 2
- Rows
- 2
- Trials
- 2
- At least: a review without a trial count
- People
- 1,743
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade C, is a meta-analysis of 1,073 people (2025) and reported mixed results.
Each row reported mixed results on its own, so there is no side to compare. The rows enrolled 670 to 1,073 people and were published from 2019 to 2025.
The rows
2 mixed- CGrade CBody measures, glucose and lipids in metabolic syndrome risk · Mixed
Meta-analysis · n 1,073 · 2025 · Adults with overweight, obesity, prediabetes, type 2 diabetes, high cholesterol, fatty liver or metabolic syndrome (23 RCTs, 19 pooled)
6–40 g a day, varied by trial · 4–16 weeks
Total cholesterol −0.20 mmol/L, LDL −0.11 mmol/L and hip circumference −1.83 cm versus control; fasting glucose did not change (MD 0.02 mmol/L, 16 trials). Waist, fasting insulin, HOMA-IR and TNF-alpha fell but with high heterogeneity.
Row on the Resistant Starch page · PubMed 41080169 (opens PubMed)
- CGrade CWeight, glucose and blood lipids · Mixed
Meta-analysis · n 670 · 2019 · Healthy adults and people with overweight, metabolic syndrome, prediabetes or type 2 diabetes (22 RCTs)
At least 8 g per day · 1 to 12 weeks
RS2 lowered triglycerides slightly in healthy people (-0.10 mmol/L) and body weight in people with type 2 diabetes (-1.29 kg), but these results leaned on a few small studies; there was no effect on any other metabolic outcome.
Row on the Resistant Starch page · PubMed 31398841 (opens PubMed)